Moderna, Racing for Profits, Keeps Covid Vaccine Out of Reach of Poor

Home » Business » Moderna, Racing for Profits, Keeps Covid Vaccine Out of Reach of Poor

Moderna’s market value has nearly tripled this year to more than $120 billion. Two of its founders, as well as an early investor, this month made Forbes magazine’s list of the 400 richest people in the United States.As the coronavirus spread in early 2020, Moderna raced to design its vaccine — which uses a new technology known as messenger RNA — and to plan a safety study. To manufacture the doses for that trial, the company received $900,000 from the nonprofit Coalition for Epidemic Preparedness Innovations.The nonprofit group said Moderna had agreed to its “equitable access principles.” That meant, according to the …

Read More